IRCT20190727044343N3招募中2 期
Evaluation of ANIF1 antiviral drug in COVID-19 patients: A Randomized Clinical Trial
Mazandaran University of Medical Sceinces0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •COVID-19 diagnosis based on Lung Ct-Scan
- •COVID-19 diagnosis based on RT-PCR
- •Lymphopenia less than 1100
- •fever more than 38 degrees
- •Positive CRP
- •Positive respiratory symptoms
- •Gastroitestinal symptms
排除标准
- •intubated patients with severe respiratory disease
- •patients with severe co-morbidity and end stage disease
- •Oral intolerance
- •onset of symptoms more than 10 days
- •pregnant women
- •severe Immuncompromised patients
研究者
相似试验
进行中（未招募）
1 期
Safety and Efficacy of Favipiravir in COVID-19 Patients with Pneumonia-A randomized, double blind, placebo- controlled studyPatients diagnosed with COVID-19 by positive PCR for SARS-COV2MedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-002753-22-ESFerrer Internacional, S.A.100
已完成
Unknown
Clinical Performance Verification Study of "COVID-19 Ag Rapid Saliva Test Device" for Diagnostic Aid of SARS-CoV-2 InfectioCOVID-19JPRN-UMIN000049723BIC GROUP Ltd.120
进行中（未招募）
1 期
Skutecznosc leczenia amantadyna chorych na COVID-19COVID-19EUCTR2021-000981-13-PLGórnoslaskie Centrum Medyczne im. prof. Leszka Gieca Slaskiego Uniwersytetu Medycznego w Katowicach500
已完成
Unknown
Clinical Performance of Coronavirus (COVID-19) Antigen Rapid Test Kits for the detection of COVID-19 variants in clinical samples from people aged 7-75 yearsACTRN12623000811606Koi Biotech Pty Ltd60
已完成
2 期
Efficacy of Faviprevir in COVID-19 TreatmentCOVIDNCT04351295Tanta University92